Nano Labs (NASDAQ:NA) has entered into an at-the-market offering agreement to sell its shares of Class A ordinary shares having an aggregate offering price of up to $45M. Net proceeds from the sale ...

OpenAI has begun rolling out GPT-5, the latest iteration of its flagship language model, to all ChatGPT users. The company’s CEO Sam Altman called GPT-5 “a significant step along the path to AGI” ...

New York, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on ...

New York, New York--(Newsfile Corp. - July 14, 2025) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear energy and technology company focused on ...

Hi, I'm Bill. I'm a software developer with a passion for making and electronics. I do a lot of things and here is where I document my learning in order to be able to inspire other people to make ...

NANO Nuclear Energy Inc. has launched a significant two-year irradiation testing program in partnership with the Massachusetts Institute of Technology (MIT) to analyze the behavior of nitrate molten ...

Rallybio Corporation (NASDAQ:RLYB) on Tuesday discontinued the RLYB212 program to prevent fetal and neonatal alloimmune thrombocytopenia (FNAIT). FNAIT is a condition where maternal antibodies, formed ...

NSF and NIH's National Cancer Institute have joined forces to fund a new grant program focused on interdisciplinary nanoscience and technology research with applications to cancer. The partnership ...

On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a potentially long-acting anti-myostatin antibody from AstralBio, Inc. In ...

Abstract: The accelerated development of the Internet of Things (IoT) in Fifth-Generation (5G) networks has highlighted the importance of exploring energy efficiency during run-time. It is imperative ...

NeuroSense plans to submit its regulatory dossier to Health Canada in Q2 2025, with a regulatory decision anticipated by Q1 2026. The company estimates the potential market opportunity for PrimeC in ...